Yesterday
Health start-up Eucalyptus to ditch Woolworths, cash in on Wegovy online
The $560 million company will sack staff and stop selling products at Woolworths and Priceline and concentrate on selling weight-loss drugs online in Europe and Asia.
April
Daily weight-loss pill could rival Ozempic, trial shows
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Eli Lilly issues warning for Australia as Trump signals pharma tariffs
In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.
Cheaper weight loss drugs would boost economy: study
The growing number of Australians with obesity is causing economic damage but should the taxpayer fund weight-loss drugs?
March
Reject Shop surges 110pc; Car tariffs hit; Ozempics’s widening effect
Read everything that’s happened in the news so far today.
How Ozempic and other GLP-1s are transforming much more than just waistlines
We don’t yet know how many Australians are taking the jab, but we’re certainly seeing the effects.
Ozempic maker says its Australian market could be half the population
Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can be up to $460 a month.
Eucalyptus says weight loss drugs sales are booming
A steady supply of weight-loss drugs Wegovy and Mounjaro has helped lift Eucalyptus’ revenue from $78 million to $121 million last financial year.
February
Young and slim? You still may not be safe from middle-aged spread
A study of almost 4000 people investigated how a person’s unique genetic make-up affects their risk of becoming obese in midlife.
TGA approves weight-loss drug to treat heart disease
Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart disease.
Big pharma steps up push for taxpayer-funded weight-loss drugs
Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be less costly than later treatment.
January
How intermittent fasting helps you lose weight and live longer
A systematic evaluation of 40 trials concluded that intermittent fasting works, with a typical weight loss of three to five kilograms over 10 weeks.
Ozempic could improve 42 health conditions – and make 19 worse
A major US study says weight-loss jabs can increase the risk of haemorrhoids, low blood pressure, tendonitis and osteoarthritis.
Price must be right to put obesity drug on the PBS
It is vital the gatekeepers of the scheme hold the line on the cost benefits of blockbuster drugs.
Global pharma giants push for weight-loss drugs to be added to PBS
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the popular obesity treatment.
The real reason men get belly fat (and how to get rid of it)
Research suggests it’s more harmful to be a man who is overweight than a woman who is carrying extra pounds.
It’s not just obesity. Drugs like Ozempic will change the world
It is early days yet, but glp-1 receptor agonists have all the makings of one of the most successful classes of drugs in history.
December 2024
Don’t want to get fat at Christmas? Do what the French do
They don’t start stuffing themselves with mince pies as soon as the supermarkets begin playing festive music in September, for one thing.
Why skipping breakfast in your 50s could actually make you fatter
But beware – people who have more than 30 per cent of their recommended daily calories in their first meal of the day are even more unhealthy, says a new study.
The five-day diet that cuts belly fat
Professor Valter Longo’s eating plan called “Pro-Lon” was awarded the first patent for “promoting longevity and health span”.